Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Wärtsilä completes Russian market exit

Wärtsilä Corporation, press release, 21 July 2022 at 8.25 AM EESTToday, Wärtsilä announces that it has completed its orderly exit from the Russian market following its announcement of scaling down activities in April 2022. All adjustments and closures of Wärtsilä’s operations were completed in accordance with local regulations. Throughout the various processes, Wärtsilä’s priority has been ensuring the safety and wellbeing of employees. Wärtsilä continues to strongly condemn Russia’s invasion of Ukraine. Human rights, safety and prosperity are very important for Wärtsilä. The company has

Viaplay Group acquires Premier Sports and accelerates entry into UK

· Premier Sports operates sports streaming service and TV channels available across the UK · Company holds UK rights to UEFA national team, La Liga, Scottish Cup and Scottish League Cup football, along with rugby, motorsport, ice hockey and more · Acquisition will create synergies with Viaplay streaming service in sports content, distribution and production, while boosting Viaplay’s UK brand awareness · Premier Sports has 222,000 paying subscribers and GBP 26.4 million in 2021 revenues · Viaplay to launch in UK this autumn Viaplay Group has agreed to acquire UK sports

Intrum AB – Interim results April-June 2022

· Seasonally strong second quarter with record new servicing sales, up 60 per cent compared to same quarter 2021 · Portfolio Investments delivered record gross collections, outperforming the active forecast by 15 per cent · Continued delivery on key priorities, organic growth and transformation program – with no visible adverse impact from rising economic uncertainty · Well positioned from a capacity and capability perspective to support clients’ increasing new case inflows and expanded need for our services · ONE Intrum program progressing at full speed and well on track, good

The Science Based Targets initiative has validated Alma Media’s new 1.5 Celsius degree greenhouse gas emissions reduction targets

Alma Media Corporation               Press Release                   21.07.2022    THE SCIENCE BASED TARGETS INITIATIVE HAS VALIDATED ALMA MEDIA’S NEW 1.5 CELSIUS DEGREE GREENHOUSE GAS EMISSIONS REDUCTION TARGETS   Alma Media has tightened its greenhouse gas emissions reduction targets, which cover emissions from the company's own operations (Scope 1 and 2) and from the subcontracting chain (Scope 3). Alma Media's tightened long-term targets were formally validated by the international Science Based Targets initiative organisation in June 2022.    The SBTi 1,5 ⁰C targets globally

Norfund joins Norsk Solar and Finnfund as partner in Nordic Impact Cooperation AS, an investment platform for C&I solar projects in high-growth markets

– Stavanger and Oslo: Norsk Solar (“Norsk Solar”, OSEBX ticker: NSOL) announced today that Norfund, the Norwegian Investment Fund for Developing Countries (“Norfund”) will join Norsk Solar and Finnfund as an equity partner in Nordic Impact Cooperation AS (“NIC”). NIC is an investment platform that provides equity financing in Norsk Solar projects for corporate and industrial energy buyers in select high-growth markets.Norfund’s investment in NIC represents an ownership share of 33.04%, and increases the amount of investment capital available to 19 million EUR. The NIC platform was

Bonava’s Q2 interim report 2022:More units recognised with higher margins

Second quarter, April – June 2022  · Net sales amounted to SEK 3,755 M (3,379) · The gross margin improved to 15.2 per cent (13.8) · Operating profit before items affecting comparability was SEK 338 M (257) · Operating margin before items affecting comparability was 9.0 per cent (7.6) · Profit before tax was SEK 303 M (101) · Earnings per share was SEK 2.01 (0.71) · The equity/assets ratio was 33.0 per cent (31.4) · Number of building rights amounted to 36,700 (33,800) · Number of housing units sold was 769 (1,246) · Number of production starts was 979 (1,341)

Sedana Medical AB Interim report January-June 2022

Committed to change the standard of care, with commercial progress and a strong balance sheet.Second quarter 2022 · Net sales for the quarter totalled MSEK 27 (40), equivalent to a decrease of 32% compared to 2021. At constant exchange rates, sales decreased by 34%. The decrease is a consequence of a significant decline in ventilated patients in intensive care units. · Gross profit was MSEK 19 (26), equivalent to a margin of 70% (66%). The improved margin is mainly an effect of a positive product mix, price adjustments and initiatives to reduce freight costs. · Earnings before

Half-year Report 2022

JANUARY 1 – JUNE 30, 2022 (compared with the corresponding period a year ago) · Net sales increased 27.8% to SEK 72,230m (56,496) · Sales growth, including organic sales growth and acquisitions, amounted to 19.0%. Organic sales growth, excluding exchange rate effects, acquisitions and divestments, was 16.3%, of which volume accounted for 5.5% and price/mix for 10.8%. · Price increases were implemented and further increases will be carried out in the second half of 2022 · The company’s assets in Russia have been impaired by approximately SEK 1.6bn. Furthermore, work has been

Q2 2022: results Strong demand and good operational performance

Zurich, Switzerland, July 21, 2022Ad hoc Announcement pursuant to Art. 53 Listing Rules of SIX Swiss Exchange · Orders $8.8 billion, +10%; comparable[1] +20% · Revenues $7.3 billion, -3%; comparable +6% · Income from operations $587 million; margin 8.1% · Operational EBITA[1] $1,136 million; margin[1] 15.5% · Basic EPS $0.20; -47%[2] · Cash flow from operating activities $382 million[][][][][][][][][][][][][][][][][][]KEY FIGURES CHANGECHANGE($ millions, Q2 Q2 US$Comparable[1] H1 H1 US$

Nordea Bank Abp: Repurchase of own shares on 20.07.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares20.07.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 20.07.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XHEL 312,940 9.32 2,917,570.91CEUX 264,756 9.33 2,471,117.79TQEX 29,362 9.34 274,189.62XSTO 320,331 9.34 2,993,189.24

Interim report January-June 2022

Sales growth remains high in the interim report for VBG Group, January-June 2022.Second quarter of 2022 · Consolidated sales increased by 23.3% to SEK 1,141.3 M (925.5). · Adjusted for exchange rate changes and acquired volume between the years, organic growth was 10.3%. · Gains from the sale of Mobile Climate Control’s property in Indiana (US) had a positive impact on operating profit (EBITA) of SEK 18.8 M. · Mobile Climate Control incurred non-recurring costs of SEK 6.7 M in conjunction with moving the US production facility. · Operating profit (EBITA) amounted to SEK 147.

DNB Markets - VEF: This too shall pass

VEF’s Q2 NAV fell 40% QOQ, which we believe reflects conservatism from VEF, as its largest asset, Creditas, recently received funding from new investors at a 100%+ higher valuation than VEF’s NAV. The market is unlikely to dismiss private fintech-related events such as Klarna’s ~85% down round as an anomaly. However, as VEF is trading at a 44% discount to its Q2 NAV, the market appears to be implicitly pricing in an IRR of -5% on its invested capital over the next three years (versus its 18% 7-year NAVPS IRR and exits at ~27%). We have cut our fair value to SEK3.4–4.8 (6.3–7.4).Q2 takeaways.

Sinch initiates search for new CEO

Stockholm, Sweden – July 20, 2022 – Sinch AB (publ), a global leader in cloud communications and mobile customer engagement, today announced that Sinch CEO Oscar Werner steps down from his position, effective as of today’s date. The board of directors has appointed Johan Hedberg as interim CEO and will now initiate the search for a new CEO. Johan Hedberg is one of the company’s founders and was CEO from 2010 to 2018.   Over the past few years, Sinch has combined organic growth and strategic acquisitions to establish a leading position in the global market for cloud communications and

MRSI Systems, Mycronic Group announces a new collaboration to provide LiDAR solutions for the Automotive Industry

MRSI Systems is delighted to announce a new collaboration with Lumentum Operations LLC ("Lumentum ", NASDAQ: LITE), a leading global photonic chip and module supplier for the automotive LiDAR industry. This collaboration promises to generate innovative LiDAR solutions for the industry.LiDAR (light detection and ranging) technology is becoming the standard equipment in medium-end and high-end vehicles. In the next five years, the demand for automotive LiDAR in advanced driver assistance systems (ADAS) applications will grow at a compound annual growth rate (CAGR)

ABS and SHI JDP to Develop Smart Hull Monitoring Software

Boosting SHI Monitoring Platform with Smart Technology (SEOUL) ABS and Samsung Heavy Industries Co., Ltd. (SHI) have signed a joint development project (JDP) to enhance hull safety with smart ship technology for Structural Health Monitoring (SHM) using a hull sensor package that will allow for more informed and targeted hull surveys. SHI’s Hull Stress Monitoring System (HSMS) will be developed in accordance with the ABS Smart Functions Guide. The system will be installed on a new build container ship scheduled for delivery in 2024. The HSMS software will be integrated into

#22-251 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 20.07.2022

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION    20.07.2022 at 18:30 EET   ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 20.07.2022   Date 20.07.2022  Exchange transaction Buy  Share class ALEX  Amount 151  Average price/share 7.7000   EURHighest price/share 7.7000 EURLowest price/share 7.7000 EURTotal price 1,162.70 EUR        The shares held by Alexandria Pankkiiriliike Oyj on 20.07.

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 20.07.2022

Fiskars Corporation   Stock Exchange Release 20.07.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 20.07.2022   Date 20.07.2022  Exchange transaction Buy  Share class FSKRS  Amount  4,100  Average price/share 18.4333 EURHighest price/share 18.5200 EURLowest price/share 18.1800 EURTotal price 75,576.53 EUR        The shares held by Fiskars Corporation on 20.07.2022:   FSKRS 875,011       On

#22-250 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Scandinavian ChemoTech announces that TSE™ therapy has been initiated at Ulis Medical Centre in Ukraine

After concluding the training of doctors, nurses and support staff at Ulis Medical Centre in Ukraine last week, the program started today and the first patient was treated.Today the first treatment with Tumour Specific Electroporation - TSE™ was performed at Ulis Medical Centre in Ukraine to treat a woman with invasive squamous cell carcinoma (skin cancer). The therapy was performed with support from ChemoTech’s application team and ChemoTech’s Medical Adviser Dr. Suhail Mufti.   Since the treatment was performed under the intended use of TSE™, it is part of the general TSE™-program

New patent approval in Hong Kong for Episurf Medical

The Intellectual Property Department (IPD) of Hong Kong has granted another patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “Tools for assisting in osteotomy procedures, and methods for designing osteotomy tools”, relates to surgical instruments in Episurf Medical’s Episealer® Talus technology for the ankle. "The patent covers Episurf’s individualised osteotomy guide, developed for optimised clinical outcomes when treating difficult to reach ankle lesions. This device is an important part of the Episealer® Talus technology which is available in the Hong Kong market”,

/Finspång’s healthcare center-original art and architecture with a long lifespan

Beautiful architecture and inspiring design characterize Finspång’s new healthcare center in Sweden, where unique art can be found among the common areas but also on the walls of the building structure. The project has received the award Miljöbyggnad Silver, where they have worked a lot on a construction technology that has a long lifespan. Energy savings have been made through solar panels that are located on the roof and an outstanding glass and aluminum facade can be found in the health center’s courtyards, among other places. Through GlasLindberg, SAPA has delivered facades and doors in

FDA announces an Oncologic Drugs Advisory Committee meeting to discuss benefit/risk profile of Oncopeptides’ Pepaxto

STOCKHOLM — July 20, 2022 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases, today announces that the US Food and Drug Administration (FDA), has announced a forthcoming public advisory meeting of the Oncologic Drugs Advisory Committee (ODAC), on September 22, 2022, to discuss the benefit/risk of Pepaxto[®] (melphalan flufenamide).On January 21 Oncopeptides announced that it has rescinded the October 22, 2021, letter requesting a voluntary withdrawal of the New Drug Application (

There are no items matching the current filter
There are no more items matching the current filter
Back to top